Skip to content

A non-control case series study of Yiqi Tongluo formular (Yiqi dredging prescription) in the treatment of Qixu Xueyu Zheng (Qi deficiency and blood block)

A non-control case series study of Yiqi Tongluo formular (Yiqi dredging prescription) in the treatment of Qixu Xueyu Zheng (Qi deficiency and blood block)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002113
Enrollment
Unknown
Registered
2012-04-10
Start date
2012-04-16
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery phase of cerebral infarction, stable angina pectories, early stage diabetes mellitus

Interventions

single cohort:Yiqi, dredging prescription intervene syndrome

Sponsors

Dongzhimen Hospital, Beijing University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient with one or more of three diseases, recovery phase of cerebral infarction, stable angina pectories, early stage diabetes mellitus, to be with Qixu Xueyu zheng, without obvious other complicated signs. Patients with cerebral infarction should be 35 to 80 years old, onset the disease within 2~6 weeks and 5-22 scores of NIHSS; Patients with stable angina pectories should be 40~70 years old, >=2 attacks angina a week; Patients with diabetes mellitus should be 18 to 75 years old with a stable blood pressure lower than 90 mmHg of diastolic pressure. All patients should signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients complicated with severe liver, kidney, blood system, endocrine system diseases and bone joint disease; 2. Patient using other Chinese medicine or Chinese therapy; 3. Trasient ischemic attach patient; 4. Intracerebral or subarachnoid hemorrhage patients; 5. Stroke caused by brain tumor, traumatic brain injury, blood disease; 6. Cerebral embolism caused by rheumatic heart disease, coronary heart disease or other cardiac diseases complicated with atrial fibrillation; 7. Mental disorder or severe dementia; 8. Patient with stroke history and its sequala will affect research; 9. Patients with severe aphasia will affect collect information; 10. Patient with lacunar cerebral infarction; 11. Patient with AMI within last three months, IV grade or severe angina, other cardiac diseases, severe neurosis, Menopause syndrome, Chest pain caused by cervical spondylosis, Biliary, source of esophageal chest pain; 12. Patient complicated with hypertention grade II and severer, severe heart and lung disfunction, severe arrhythmia (rapid atrial fibrillation, paroxysmal ventricular tachycardia, atrial flutter); 13. Pregnancy or one has plan to pregnancy, lactation woman; 14. Urinary albumin excretion rate caused by other original diseases such as chronic nephritis, hypertension, gout, lupus erythematosus; 15. Renal vascular hypertension; 16. Patient with history of critical diseases, such as malignant hypertension, myocardial infarction, cerebral vascular accident, diabetic ketoacidosis within last six months; 17. Patient with congestive heart failure grade I~IV; 18. Patient complicated with cancer; 19. Poor complaince; 20. Allergic person; 21. Person who attended other clinical trial in last three months.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese medicine intervene the debility blood stasis syndrome;The average work hours and average recovery time of syndrome;

Contacts

Public ContactGao Ying
gaoying973@126.com+86 13366275973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026